Abbreviations: 38 HBV, Hepatitis B Virus; CHB, chronic hepatitis B; ECM, extracellular matrix; HepPar-1, 39 hepatocyte Paraffin 1; HNF4a, Hepatocyte nuclear factor 4 alpha; hepatitis B e 40 antigen (HBeAg); covalently closed circular DNA (cccDNA); IT, immune tolerant; IA, 41 immune active; ENH, hepatitis B e antigen negative hepatitis; ISH, in situ 42 hybridization; HSC, hepatic stellate cells; HBsAg, Hepatitis B Surface Antigen; AgNOR, 43 argyrophilic nucleolar organizer region, IP-10, Interferon gamma-induced protein 10. 44 45 46 3 Abstract 47 Chronic Hepatitis B Virus (HBV) infection is strongly associated with the progression of 48 liver fibrosis, cirrhosis and hepatocellular carcinoma. Despite intensive study, the 49 detailed mechanisms leading to HBV induced liver disease have not been fully 50 elucidated. Previously, we reported a mosaic distribution of viral antigens and nucleic 51 acids at single-cell level in liver tissues of chronic hepatitis B (CHB) patients and 52 proposed a 'three-stage model' of HBV infection in vivo. Here, we explored whether 53 the different stages at cellular level is functionally linked with fibrogenesis. We 54 observed a tight spatial relationship between the invasion of collagen fibers and 55 transitions from S-rich to DNA-rich stage. While S-rich cells mainly localized within 56 minimally fibrotic tissue, DNA-rich cells were often closely surrounded by a milieu of 57 stiffened extracellular matrix (ECM). cDNA microarray and subsequent validation 58 analyses revealed that S-rich cells manifested elevated ribosomal proteins and 59 oxidative phosphorylation genes in a disease phase-dependent manner. On the other 60 hand, DNA-rich cells exhibited gradually deteriorated expression of hepatocyte-61 specific antigen and transcriptional regulator in parallel with the progression of hepatic 62 fibrosis. Finally, during fibrogenesis, inflammatory genes such as IP-10 were found to 63 be expressed in both portal infiltrated cells and surrounding parenchymal cells which 64 resulted in suppressed antigen expression. Taken together, we propose that liver 65 inflammation and accompanying fibrogenesis is spatially and functionally linked with 66 the transition of virological stages at cellular level. These transitions occur possibly due 67 to an altered hepatocyte transcription profile in response to a transformed ECM 68 4 environment. The collective viral and host activities shape the histological alterations 69 and progression of liver disease during CHB infection. (262 words) 70 71 72 5 Introduction 73 Globally, hepatitis B virus (HBV) chronically infects over 240 million people. Patients 74 with chronic hepatitis B (CHB) often develop liver fibrosis, cirrhosis and hepatocellular 75 carcinoma, which results in over 780,000 deaths annually(1). Currently available 76 antivirals such as nulceot(s)ide analogs and pegylated interferon can effectively control 77 viremia and lower the risk of CHB related liver disease, but sustained off-treatment 78 responses are still rare(2). Novel therapies are in development with the goal of 79 'functional cure' which is defined by the loss of Hepatitis B Surface Antigen (HBsAg), 80 hopefully together with appearance anti-HBsAg and tight immune control of 81 intrahepatic HBV covalently closed circular DNA (cccDNA). 82 Among the challenges on the way to HBV cure, the limited knowledge on the 83 intrahepatic virological and immunological events in the context of liver pathological 84 changes during the course of CHB infection represents a major one. Although the 85 natural history of CHB is quite complex and variable among individuals, it is commonly 86 regarded as consisting of four phases (3, 4), i.e., immune tolerant (IT), immune 87 clearance or immune active (IA), non/low-replicative or HBV carrier, and hepatitis B e 88 antigen negative hepatitis (ENH). These phases have been defined by specific 89 biochemical, serological and virological parameters, including serum ALT levels, 90 hepatitis B e antigen (HBeAg) serostatus, and serum viral load. During the natural 91 course of CHB infection, hepatic inflammation and accompanying liver fibrosis often 92 develop, which is much more prevalent and severe in IA and ENH phase.
HBV DNA, viral or host antigen and Sirius Red triple staining 147 The protocol for in situ hybridization of HBV DNA in formalin-fixed paraffin embedded 148 (FFPE) sections of liver biopsies were performed as described previously (6) using a 149 pan-genotype probeset (genotype A-D, VF6-20095, Affymetrix, CA. USA). Sections 150 were stained with NBT (Nitroblue tetrazolium) and BCIP (1,5-bromo-4-chlooro-3-151 indolyl-phosphate, Roche, Switzerland) in developing solution at 37 ℃ for 2 hrs. 152 Sections were then immuno-stained with antibody against HBsAg or HNF4a, at 4℃ Single and double in situ hybridization of RNA and DNA 159 The method for ISH of IP-10 mRNA was similar to that of HBV DNA except that all the 160 solutions used before hybridization step were pre-treated with diethyl pyrocarbonate. 161 Signal was developed with either NBT/BCIP or fast red. For double ISH of HBV DNA and 162 IP-10 mRNA, IP-10 signal was first developed using NBT/BCIP followed by inactivation 163 of the label probe (6-AP) with AP stop QT for 30min at room temperature and then 164 incubated with the other label probe (1-AP) for 15min at 40 degree. After washing, 165 signal was developed with INT (p-Indonitrotetrazolium, Sigma-Aldrich) and BCIP (1,5-166 bromo-4-chlooro-3-indolyl-phosphate, Roche, Switzerland).
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Combined FISH and immunofluorescence staining 168 Cryosections were used for HBV DNA FISH. Briefly, sections were baked at 37℃ for 5 169 min followed by a 5 min fixation with 3.7% neutral formalin. After protease digestion 170 for 10min at 37℃, sections were refixed for 5min and hybridized with HBV DNA 171 probeset. After bDNA amplification, FISH signal was developed with Fast Red according 172 to the protocol of Affymetrix tissue kit. Immuno-staining of type I collagen were then 173 performed at 4℃ overnight followed by incubation with AF488 labeled goat-anti-174 rabbit antibody (Thermo). Sections were finally counterstained with Hoechst 33342 175 and mounted with Dako fluorescent mounting medium (S3023). The AgNOR staining of nucleoli was performed essentially as described(7). FFPE 178 sections were routinely dewaxed through xylene and graded alcohol to distilled water.
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Slides were then immersed in 0.01M sodium citrate buffer pH 6.0 and boiled at 120℃ 180 for 20min in a wet autoclave. After cooling down and washing, slides were incubated 181 with fresh prepared 33% silver nitrate in a solution containing 0.6% gelatin and 0.33% 182 formic acid prepared with ultrapure water. Slides were stained at 37℃ for 13min. The 183 slides were then washed extensively with distilled water and blocked with 10% FBS in 184 PBS. Anti-HBsAg was incubated at 4℃ overnight followed by HRP labeled secondary 185 antibody and AEC staining. 186 cDNA microarray and quantitative RT-PCR analysis 187 A total of 25 samples were included in the microarray analysis. We included samples 188 with the following criteria, IT phase (n=8), HBeAg positive, HBV DNA >10 7 copy/ml, 189 G score 0-2, S score 0-1, ALT<50 IU/L; IA phase (n=6), HBeAg positive, HBV DNA >10 5 190 copy/ml, G score 0-2, S score 0-1 ALT>80 IU/L; carrier phase (n=5) , HBeAg negative,
191
HBV DNA< 10 5 copy/ml, G score 0-1, S score 0-1, ALT <60 IU/L; normal control (n=6), Graphpad Prism 6.0 was used for most statistical analyses. One-way ANOVA test was 220 used for qRT-PCR data. Student's t test was used for analyses in HBsAg transgenic mice.
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The in situ hybridization and other combined staining results were examined by two 222 independent pathologists. To further inquire the underlying mechanism leading to the ECM modulated cellular 268 state, we took advantage of the microarray dataset generated from liver biopsies from 269 CHB patients (122 cases in total), which had been previously analyzed from various 270 aspects(10-12). Since the included samples spanned all four phases and various degree 271 of liver inflammation and fibrosis, the differential genes recovered were mostly related 272 to fibrogenesis and immune-related pathways. We reasoned that in order to reveal 273 host genes directly modulated by viral replication or expression in the context of 274 overwhelming secondary inflammatory fibrosis related genes, we needed to stratify Supplementary Table 2 ). More interestingly, the differential genes 296 within these two pathways showed an astoundingly unanimous trend among these and oxidative phosphorylation genes were most likely caused by viral antigens. 305 We further confirmed the differential genes by qRT-PCR in additional 42 samples with 306 similar inclusion criteria ( Supplementary Figure 7) . Interestingly, ribosomal and 307 mitochondrial respiratory genes showed much higher elevation in three samples of Figure 8A) . To evaluate the ribosomal contents within S-rich cells, we The liver inflammation is inseparable from fibrogenesis during the development of 381 CHB-related liver disease. We next tried to probe the spatial relationship among 382 20 inflammatory gene expression, viral DNA/antigen and the collagen fibers. We chose 383 IP-10 as an example due to its relatively robust and universal induction in many cell 384 types. We first examined the expression of IP-10 in the context of HBsAg 385 ( Supplementary Figure 11 A-D) and collagen fibers ( Supplementary Figure 11 E-H) . 386 Indeed, IP-10 was not only expressed in infiltrated cells, but also in parenchymal cells Supplementary Figure 12 arrowhead ). In addition, IP-390 10 signal was also seen in S positive cells, although the level of HBsAg was much lower 391 than that in IP-10 negative cells ( Supplementary Figure 11 . C, G, Supplementary Figure   392 13 arrowhead), suggesting that these cells were also influenced by inflammation. 393 Interestingly, IP-10 was found not to be restricted in IA patients, as it can be observed 394 in some IT patients as exemplified in one particular case with ALT value of 41 IU/L 395 ( Supplementary Figure 12, 13) . This reflected the limitations of disease phase 396 categorization solely based on blood tests. 397 We next attempted to perform a triple staining, in which IP-10 signal was developed 398 by NBT/BCIP (blue-purple), HBV DNA was then developed by INT/BCIP (yellow) and 399 HBsAg was finally stained using AEC (red). Again, we found that IP-10 high cells were 
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In this study, we unexpectedly found a close spatial relationship between the single-425 cell virological state, i.e., S-rich and DNA-rich state, and the deposition of collagen 426 fibers. In carriers and IT patients, clusters of S-rich cells were usually located in 427 minimally fibrotic tissues, whereas in IA patients, DNA-rich cells, were more frequently 428 found to be spatially related to the growing collagen fibers compared to S-rich cells.
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This led us to speculate that the S-rich, DNA-rich transitions might be the result of an 430 altered cellular state directly caused by the changes in the extracellular milieu. 433 In order to look into the detailed mechanism leading to the aforementioned 434 phenomenon, we utilized a previously published cDNA microarray dataset of CHB liver 
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